Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since they cancelled them again, that’s -447,190,272 warrants, which is basically a share buyback, am oi roight?
I’m not very experienced with dilution so don’t have much frame of reference for appropriate versus excessive dilution. In the past year, the company has been engaged in international activities, initiated field testing in the O&G field, and has expanded its distributor network. Those activities all take money, which can come from revenues or selling shares.
I guess it’s all determined in retrospect. If things take off for PCTL, 27% increase in shares over a year may be determined to be worth it. If not, then this dilution will be considered bad or not worth it.
Thanks for having that info at hand, I couldn’t recall when the last time the share structure changed.
Dilution is a matter of scale and timeframe. Companies sell shares to exist and grow. Has this company diluted in the past two years? For sure. Have they diluted in an unacceptable or inappropriate way in the past year? That’s a big no, IMO.
Nah, wrong ticker. This one just released news of cancelled warrants. Not sure what you’re looking at but this is PCTL.
This is clearly a net positive for the company and it is unclear how/why you are saying it’s a negative for the company.
Speculative and wrong.
This whole post is speculative.
That’s a good distinction and one I can agree with. There have been some questionable statements that I can’t quite see how they were made in good faith and with a straight face.
I recall differently, explicit statements from the CEO that there were no plans for a RS “in the next year at least” if memory serves.
Any evidence a RS has ever been discussed, talked about, planned? Anything at all?
I think in the hyperfixation on wanting some info that will immediately create a 30-300% PPS pop, what is being lost is the actual forward progress of the oil field testing. We have gone from phase 1 testing to analyzing the results to those results being good enough for other companies to joint venture in business efforts based on those results. Many have been preaching patience for the two years I’ve been here but we are at a point where patience may very well be rewarded handsomely if this forward progress continues.
Not gonna do your DD for you… go check OTCMarkets.
Lol investing is boring… if you want excitement, you should swing trade or day trade.
These relationships that you and many others on this board have been slamming for the two years I’ve been here? “These worthless employees, no pedigree, no experience, not doing crap for the company.”
Company gets rid of said employees.
“He’s abandoning his people! What a horrible CEO”
Right no matter what, eh?
MaxxxxxxGgrrrreeeeeeeennnnnnn
Haha now that’s funny.
You’ve had some good points over time but vague, attention seeking statements like this should be beneath you.
I’m so exhausted from watching this same tennis match, back and forth on, on this board. The company is frustratingly quiet on the PR front and it’s unclear if that’s a good thing or a bad thing (given the history of inaccurate info in previous PRs) but I’m afraid it’s not a reflection of great things happening. I hope I’m wrong, but more importantly I don’t think I am gaining anything from reviewing this board frequently anymore so it seems like it’s time a break. I hope when I return we are sitting pretty above .05 and have some real, substantive news on revenue streams.
Prestige Worldwide!
Proof?
Wow that’s a lot of shares.
Yea, there is nothing in his tweets about that.
Your track record on call sub penny speaks for itself, for those interested in researching it a little. Lengthy daily streak of being wrong.
Same as always, high risk high reward. Like almost all OTC companies, struggling to survive and find their way to success. Don’t invest what you can’t afford to lose.
Thank you for elaborating.
Speculating much? Upon what basis do you expect additional toxic debt?
Man, you’re the most back and forth person on here.
Nope, not at all. Everyone can see that, it’s quite evident. Typically, you have higher than 101 level critiques is all I was saying. Jimr can point to the yield sign, I rely on you for actual critically thought through criticism of the company.
Thank you for the input you have provided during your time here.
Your criticisms have always been sophisticated and informed, now it’s this?
You’re correct, if you go on YouTube it’s the same video that was released previously it was just re-released, or that’s what I see as happening. It does reassure me, though, that maybe PCT Europe is still involved with NTH solutions.
I think there have been several “releases” of the same video, one very recently.
So you think they will never file, ever ever? They’re done as a company forever?
No loss here, I’m up about 100% overall still.
Lol oh jimr... why are you the only person that replies to your posts? Sometimes I want to throw you an atta boy but they’re just so bad. I’m sorry.
I wish I had some phenomenal insight or predictive abilities. In regard to your other post about the reverse split, I don't think it would be helpful unless we had an absolutely nailed in reason for it. I know a lot of times they talk about it bringing in a new level of investor, in some situations it allows for movement to a different exchange or different designation in the OTC, but it's not really used that way nearly 100% of the time. Given the company's inaccurate (intentional? unintentional? who knows) presentation of information, I think any R/S announcement would be met with speculation, ridicule, and likely a decent exodus of folks for whom this would further "confirm" their negative sentiments. I will be happy if O/S count remains steady and any increase is directly addressed (ideally preemptively) by the company explaining it's being utilized in a productive manner.
I do think there are a lot of positive things potentially happening here but it's taking a really long time for them to manifest. I love the number of distributors but the lack of revenues in the filed financials is a bit confusing and almost disconcerting to me. I expected a slow and gradual rise in revenues because a number of those distributors seem to be growing, expanding, and doing well. Unlike some, I don't expect the company to disclose the financial details of their contracts and distributorship agreements, but they could offer a range or somehow provide some insight for shareholders.
The UK variable has been explored up, down, and sideways. I sure do hope something manifests there but unlike others I'm not too optimistic. When I read that NHS document, I worry that the trust utilized PCT Europe to run the tests and verify the efficacy of hypochlorous acid then created their own HOCL production and distribution systems in-house. I don't know much about how patent law works with international borders, but even assuming that the patent on the tracking and RFID system holds in the UK the company doesn't have a patent on HOCL. So the hospital could just say "yea, this stuff works, we are going to produce it on site and put stickers on the bottles when we produce it" which isn't a violation of the patent in any way. The fact the trust published document talks about reinvesting their profits into the trust and that PCTL is no longer a shareholder in the PCT Europe filings is a bit concerning to me. I hope I'm wrong and I very well could be, but I'm not making my stand on the UK potential.
The oil and gas stuff is obviously the hot topic and from my layperson's reading of the phase 1 results it looks pretty hopeful. I have no idea how long the entirety of the testing process takes to get to a point where oil companies and producers are like "heck yea, that's legit, let me get some" but I hope some of them are willing to jump the gun based on initial testing results and not wait until all the phases are done. Patience is not something that OTC investors have in abundance, however, so that combined with the company's spotty history of PRs and consistent, accurate info makes for a volatile path in front of us.
I think the citrus application is really an underexplored area and I get the company doesn't have the resources to explore everything. They did testing in 2017 or 2018, good results, but the FDA requires some pretty high thresholds be met in general and especially if this would be the only application to address the issue plaguing the citrus industry. If the company could find the resources to explore that avenue, it would be great. Similar to the oil and gas stuff though, lots of phases and time which doesn't bode well because the need for money to get that is what leads to reverse splits, dilution, and other bad things.
I still think the money here is in the patent and they need the right marketing or sales team speaking to the right parties about it. The Annihilyzer was developed to address HAIs, which cost hospitals tens of billions of dollars a year in treatment they have to provide out of their own pockets. Ounce of prevention, pound of cure, all that. If the company were speaking to liability lawyers, hospital administrators, and folks who were thinking about liability and how to protect themselves in a lawsuit and save money, that's a way better approach to me than talking to medical personnel. Hell, they may have been talking to those people, but if they are I think they're doing a poor job of presenting the true benefit of the RFID tracking system - legal liability protection.
Probably a much longer answer than you wanted but it's my 52 cents on a Friday evening. I wish I was closing in on a couple million shares, I've got about half a million. Almost two years in, I sold for the first time (100,000 shares) a few weeks ago then bought it back at a slightly lower price. I worry if the first quarter revenues are a decline we will likely see some exodus also but those folks may be replaced pretty quickly because there are a lot of potential catalysts. There are also a lot of way worse OTC companies in a lot of ways than this one. Thanks for coming to my Ted Talk, I hope you have a good weekend :)
Haha I’m in that exact boat, I opened up an E*TRADE account the last time the stop sign was up so I could keep buying.
You’re totally right, they’re NEVER going to come out, like NEVER EVER, and the company is going to close. Thanks for the great DD on that.